Alfuzosin PCD Pharma Franchise Company
Cafoli Lifecare offers the Alfuxyle range of Alfuzosin tablets for pharma distributors, medical agencies, stockists, and PCD franchise partners across India — covering plain Alfuzosin 10mg and the Alfuzosin + Dutasteride combination for complete BPH management.
What is Alfuzosin?
Alfuzosin is an alpha-1 adrenergic blocker used to treat the symptoms of benign prostatic hyperplasia (BPH) — an enlarged prostate. It relaxes the muscles of the prostate and bladder neck, making urination easier (PubChem, NCBI).
Our Alfuzosin Product Range
| Brand | Composition | Packing | MRP |
|---|
| Alfuxyle 10 Tablet |
Alfuzosin 10mg |
10×10 Alu Alu |
₹199 |
| Alfuxyle D Tablet |
Alfuzosin 10mg + Dutasteride 0.5mg |
10×10 Alu Alu |
₹299 |
Plus additional Alfuzosin formulations — contact us for the complete list.
Therapeutic Applications
The Alfuxyle range serves BPH symptom management in men, typically as long-term daily therapy. Prescriber base: urologists, nephrologists, and general physicians managing aging male patients.
Why Alfuzosin is a High-Potential Molecule for Distributors
BPH affects a majority of men above 60, and India’s aging population is expanding this patient pool every year. Alfuzosin therapy is continuous — often lifelong — giving distributors highly predictable monthly repeat sales, and the Dutasteride combination captures the premium combination-therapy segment.
Why Choose Cafoli Lifecare
Monopoly rights based franchise model, WHO-GMP manufacturing, DCGI-approved portfolio, promotional inputs (visual aids, MR bags, product cards), fast dispatch, and competitive net rates — trusted by 1000+ franchise partners across India.
References
- NCBI PubChem — Alfuzosin Compound Summary
- PubMed (U.S. National Library of Medicine) — Published research on Alfuzosin
Our formulations of Alfuzosin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: